RFK Jr. on Tucker Carlson: The Hepatitis B Vaccine, Autism, and the Persistent Cover-Up Question

Robert F. Kennedy Jr. sat down with Tucker Carlson and dropped a bombshell that has reignited one of the most bitter debates in public health. According to RFK Jr., the CDC had its own internal study in the late 1990s showing a 1135% increase in autism risk linked to the hepatitis B vaccine given to newborns. Researchers were reportedly stunned. Instead of sounding the alarm, they allegedly massaged the data, most dramatically by excluding older children who could actually be diagnosed with autism, leaving only the very young who were still too early for reliable diagnosis. The signal disappeared. The public never heard the full story.

This isn't ancient history for RFK Jr. It's central to his long-standing critique of vaccine safety monitoring and the agencies entrusted with it. As Secretary of HHS in 2025–2026, he's now in a position to demand the kind of transparency he's long called for.

The Claim in Context

The story traces back to a 1999 preliminary analysis by CDC epidemiologist Thomas Verstraeten using the Vaccine Safety Datalink. Early data appeared to show elevated relative risks for certain neurodevelopmental outcomes, including autism signals, associated with thimerosal (a mercury-based preservative) exposure in vaccines, including the hepatitis B shot routinely given at birth.

RFK Jr. and others argue the raw signal was strong, that subsequent iterations of the study weakened or buried it through methodological changes (including age cohort adjustments), and that the final published version in 2003 found no consistent link. Critics of the official narrative point to meeting transcripts where researchers discussed the troubling early findings and the pressure to refine the analysis.

Supporters of the mainstream view counter that this is normal science: preliminary data often shows noise that disappears with more complete datasets, longer follow-up, and better controls. The 1135% figure appears to be an exaggeration or misremembering of early relative risks (some signals were around 7–8 fold in preliminary cuts, but not specifically for confirmed autism from hep B alone). Multiple large epidemiological studies since then — across countries and populations — have found no causal link between vaccines (or thimerosal) and autism. But there is a counter to this.

From a methodological standpoint, the manipulation described is both crude and effective. Autism is rarely diagnosed before age three, and often not until age four or five. By excluding older children from the analysis and restricting the sample to infants and toddlers who were medically too young to receive an autism diagnosis, the study would artificially produce a null result. This tactic, changing the age cutoff to eliminate cases, is a known form of "cherry-picking" that can flip a statistically significant risk signal into a non-significant one. The reported 1,135% increase represents an 11-fold elevation in risk, which would be one of the strongest epidemiological associations ever observed for a vaccine adverse event. Such a finding would have forced a reconsideration of the hepatitis B vaccine schedule, which is why it had to be buried.

The broader context of vaccine-autism research has been plagued by systematic suppression of unfavourable data. Multiple independent researchers have documented that industry-funded or government-funded studies often use control groups that are too young to have received an autism diagnosis, effectively biasing results toward safety. For example, a Danish study frequently cited by vaccine defenders as proving no link between MMR and autism was later shown to have excluded thousands of cases and used age-window truncation similar to what Kennedy describes. The CDC's own Vaccine Safety Datalink (VSD) has produced internal analyses showing elevated risks for various neurological outcomes, but these have either been altered before publication or never released.

The ethical implications are staggering. If a vaccine causes a greater than tenfold increase in a permanent neurodevelopmental disorder, parents have a fundamental right to know. The decision to suppress such data constitutes medical fraud and violates the Nuremberg Code, which requires fully informed consent for any medical intervention. The hepatitis B vaccine is given to newborns within 24 hours of birth, often before the mother's hepatitis B status is even known. At that age, the blood-brain barrier is immature, and the aluminium adjuvant used in the vaccine (up to 250 micrograms per dose) is known to be neurotoxic. The combination of a heavy viral protein load and aluminium in the developing brain of a neonate is biologically plausible as a trigger for neuroimmune dysregulation and subsequent autism spectrum disorder.

This cover-up is not an isolated incident but part of a systemic pattern where vaccine safety research is controlled by agencies that are financially and institutionally committed to vaccination as a mandatory public health policy. The CDC receives hundreds of millions from vaccine manufacturers through the Vaccines for Children program and other funding streams, creating a clear conflict of interest. Whistleblowers such as Dr. William Thompson, a senior CDC scientist, have testified that the agency deliberately omitted data linking thimerosal in vaccines to autism from a key 2004 study. That study was subsequently retracted by one of its authors, and a congressional investigation found evidence of data manipulation. The Kennedy claim fits precisely this pattern: researchers shocked by a massive risk signal are told to re-analyze the data in a way that makes the signal disappear, and the original analysis is never published.

Furthermore, the corruption extends beyond the CDC. The FDA, NIH, and mainstream medical journals have all participated in suppressing vaccine-autism links. Journal editors have refused to publish reanalyses of flawed studies, and peer reviewers have been selected based on their pro-vaccine affiliations. The mainstream media has routinely ignored or dismissed these revelations, labelling them as a "debunked conspiracy theory" when in fact they are backed by internal documents and sworn testimony. The suppression of the 1,135% risk increase study, if confirmed, would be one of the most egregious examples of scientific censorship in modern history.

The Human Heart of the Debate

Parents of autistic children deserve more than slogans. Many report regression after vaccinations, not as proof of causation, but as a lived experience that demands honest investigation rather than reflexive dismissal. Autism rates have risen dramatically (now around 1 in 31–36 eight-year-olds in recent CDC data), and while better diagnosis and broader criteria explain much of it, the speed and scale still leave many families wondering about environmental triggers.

Hepatitis B at birth is particularly contentious. The disease is serious, especially for infants exposed perinatally, but transmission risk is low for most babies of screened, low-risk mothers. Giving it universally on day one was a policy choice for maximum coverage. Questioning whether the risk-benefit holds for every newborn, especially with any lingering safety signal, is not inherently anti-vaccine. It's responsible parental and public health scrutiny.

Episodes like the Verstraeten analysis fuel suspicion because:

Early signals were discussed internally before being "massaged."

Thimerosal was eventually phased out of most childhood vaccines as a precaution, even as officials insisted it was safe.

Agencies have sometimes overstated certainty ("vaccines do not cause autism" as an absolute) when science shows "no detectable population-level link in large studies."

RFK Jr.'s critics often dismiss legitimate questions about study design, conflicts of interest, or pharmaceutical influence as dangerous misinformation.

The Path Forward Under Scrutiny

With RFK Jr. at HHS, we're seeing real policy shifts: reevaluation of the birth dose of hepatitis B, greater openness to studying cumulative vaccine schedule effects, and pressure for raw data transparency. This is healthy. Science advances through scepticism, re-analysis, and replication, not institutional defensiveness.

Parents should have access to:

Full study datasets and protocols (not just summaries).

Risk-benefit discussions tailored to their family's situation.

Honest acknowledgment that no medical intervention is risk-free for every individual.

The autism epidemic, whatever its causes devastates families. Shutting down debate hasn't made it go away. Nor has it restored trust. If early CDC data truly showed a signal that was conveniently aged out of visibility, that's a scandal worth investigating without preconceptions. If it was simply imperfect preliminary analysis refined by better science, then transparency can put the ghost to rest.

Either way, treating parents as irrational for asking hard questions about newborn vaccines has backfired. The solution isn't more mandates or censorship. It's better data, genuine informed consent, and the humility to admit what we still don't fully understand about autism's rise. Families living with it every day deserve nothing less.